BSE : GUFICBIO.BO
-$3.3 (-0.88%)
BSE
Pranav Jayesh Choksi
Drug Manufacturers - Specialty & Generic
Healthcare
GUFICBIO.BO
1491
IN
INR
0.61
1.55
0.92
0.15
0.00
$9.44B
3.97
5.65
86.29
4.33
$6.4
$642.15M
6.80%
9.17%
10.16%
4.78%
58.46
-7.39
-7.39
2/5
0 Analysts
%
4.24
3/9
$2.84B
$13.42B
$6.77B
$1.24B
No key metrics data available.
| Name | Title |
|---|---|
| Nagesh Yarrabathina | Chief Operating Officer |
| Devkinandan Roonghta | Chief Financial Officer |
| Sunil Desai | Head Human Resource Department |
| Ami Naresh Shah | Senior Manager of Legal, Company Secretary & Compliance Officer |
| Avik Das | Investor Relations Officer |
| Jayesh Pannalal Choksi | Chairman & MD |
| Pankaj Jayakumar Gandhi | Whole-Time Director |
| Pinak Padhya | Associate Vice President - Sales & Marketing |
| Pranav Jayesh Choksi | Chief Executive Officer & Whole Time Director |
| Ashok Laxman Dev | President of Operation |
No votes yet today — be the first to share your view!
About Gufic Biosciences Limited (BSE:GUFICBIO.BO) Stock
Gufic Biosciences Limited is a pharmaceutical enterprise engaged in the global development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), generic medications, and associated services. The company's extensive international presence spans India, Africa, Asia, Europe, Australia, North America, South America, and other global regions. Its production capabilities encompass APIs and bulk drug substances, including compounds for antifungals, anesthetics, immunosuppressants, and key antifungal intermediates. Additionally, Gufic Biosciences specializes in creating lyophilized injectable products across therapeutic areas such as antibiotics, antifungals, cardiology, infertility, antivirals, and proton-pump inhibitors. The firm's comprehensive portfolio also features ph ... armaceutical brands like Spark, Criti Care, Criticare Life, and Ferticare, alongside offerings in herbal medicine, aesthetic dermatology (aesthaderm), gufic stridden, and personal care products. These varied products are supplied to major hospital networks and a broad spectrum of medical facilities. Established in 1970, Gufic Biosciences Limited has its headquarters in Mumbai, India.
Frequently Asked Questions
What is the current Gufic Biosciences Limited (GUFICBIO.BO) stock price?
Gufic Biosciences Limited(BSE:GUFICBIO.BO) stock price is $373.7 in the last trading session. During the trading session, GUFICBIO.BO stock reached the peak price of $447.85 while $267.5 was the lowest point it dropped to. The percentage change in GUFICBIO.BO stock occurred in the recent session was --0.88% while the dollar amount for the price change in GUFICBIO.BO stock was -$3.3.
GUFICBIO.BO's industry and sector of operation?
The BSE listed GUFICBIO.BO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of GUFICBIO.BO?
Nagesh Yarrabathina
| Chief Operating Officer
Devkinandan Roonghta
| Chief Financial Officer
Sunil Desai
| Head Human Resource Department
Ami Naresh Shah
| Senior Manager of Legal, Company Secretary & Compliance Officer
Avik Das
| Investor Relations Officer
How many employees does GUFICBIO.BO have?
Number of GUFICBIO.BO employees currently stands at 1491. GUFICBIO.BO operates from SM House, Mumbai, MA 400057, IN.
Link for GUFICBIO.BO official website?
Official Website of GUFICBIO.BO is: https://www.gufic.com
How do I contact GUFICBIO.BO?
GUFICBIO.BO could be contacted at phone #91 22 6726 1000 and can also be accessed through its website. GUFICBIO.BO operates from SM House, Mumbai, MA 400057, IN.
How many shares of GUFICBIO.BO are traded daily?
The average number of GUFICBIO.BO shares traded daily for last 3 months was 12.63K.
What is the market cap of GUFICBIO.BO currently?
The market value of GUFICBIO.BO currently stands at $37.33B with its latest stock price at $373.7